Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate.
Exhaled breath condensate (EBC) pH appears to be a robust measure of asthma. However, the association between EBC pH and clinical factors and airway inflammatory markers remains unclear. The objectives of this study were to investigate the factors determining EBC pH in asthmatic children, and the reproducibility and effects of collection devices on EBC pH in nine healthy, nonsmoking adults. EBC was collected once from asthmatic children using EcoScreen, and from adults over 3 consecutive days using both RTubes and EcoScreen. EBC pH was measured immediately in non-deaerated samples by microelectrode pH meter. Concentrations of 8-isoprostane, cysteinyl leukotrienes (cys-LT), and leukotriene B4 (LTB4) were measured using enzyme immunoassay. Exhaled nitric oxide concentration (FeNO) was measured by chemiluminescence. Fifty-eight asthmatics (16 intermittent, 12 mild persistent, and 30 moderate-to-severe persistent) were recruited. EBC pH was lower among patients with moderate-to-severe persistent than intermittent asthma (P = 0.046). This marker correlated inversely with disease severity score (rho = -0.276, P = 0.036), but not FeNO or other EBC biomarkers. Bland-Altman analyses found pH but not other EBC biomarkers to be reproducible, which were confirmed by its low coefficient of variation (2.7%; range, 0.4-5.2%). There was poor correlation between pH in EBC collected by RTube and EcoScreen (rho = 0.059, P = 0.784). Factor analysis selected four factors that explained 67.5% of the total variance, and EBC pH clustered with both cys-LT and LTB4. In conclusion, our results suggest that pH in non-deaerated EBC is influenced by asthma severity in children. EBC pH measurement is reproducible, but is dependent on the collection devices used.
Leung
Ting F
TF
Department of Pediatrics, Chinese University of Hong Kong, Hong Kong SAR, China. leung2142@cuhk.edu.hk
Li
Chung Y
CY
Yung
Edmund
E
Liu
Eric K H
EK
Lam
Christopher W K
CW
Wong
Gary W K
GW
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000175:diagnosis* / Q000378:metabolism; D015415:Biomarkers / Q000032:analysis; D001944:Breath Tests / Q000295:instrumentation; D002648:Child; D003545:Cysteine / Q000032:analysis; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000032:analysis; D005163:Factor Analysis, Statistical; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007124:Immunoenzyme Techniques; D007975:Leukotriene B4 / Q000032:analysis; D015289:Leukotrienes / Q000032:analysis*; D008163:Luminescent Measurements; D008297:Male; D009569:Nitric Oxide / Q000032:analysis; D015203:Reproducibility of Results; D012720:Severity of Illness Index
D015415:Biomarkers; D015289:Leukotrienes; C112381:cysteinyl-leukotriene; D007975:Leukotriene B4; C075750:8-epi-prostaglandin F2alpha; D009569:Nitric Oxide; D015237:Dinoprost; D003545:Cysteine